EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Time to Treatment Discontinuation and Cost Effectiveness of Third-Line Therapies in Advanced Colorectal Cancer: Real-World Evidence from the NIH All of Us Research Program

Patrick J Kiel, Mark W McGiffin, Todd C Skaar, Michael A Preston

Drugs - Real World Outcomes · 2026-03 · 13 (1) · 121-131

DOI: 10.1007/s40801-026-00539-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drugs - Real World Outcomes, online erschienen am 10.03.2026. Verfasst von Patrick J Kiel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, RURaL Lab for D&I Research in Cancer Disparities, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN, 479…. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pharmacy Practice, RURaL Lab for D&I Research in Cancer Disparities, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN, 47907, USA.
  • Indiana University, Indianapolis, IN, USA.
  • Department of Pharmacy Practice, RURaL Lab for D&I Research in Cancer Disparities, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN, 47907, USA. mapreston@purdue.edu.
  • Center for Health Excellence, Quality and Innovation (CHEQI), College of Pharmacy, Purdue University, Indianapolis, IN, USA. mapreston@purdue.edu.

Zitieren

APA

Kiel, P. J., McGiffin, M. W., Skaar, T. C., & Preston, M. A. (2026). Time to Treatment Discontinuation and Cost Effectiveness of Third-Line Therapies in Advanced Colorectal Cancer: Real-World Evidence from the NIH All of Us Research Program. Drugs - Real World Outcomes, 13(1), 121-131. https://doi.org/10.1007/s40801-026-00539-9

Vancouver

Kiel PJ, McGiffin MW, Skaar TC, Preston MA. Time to Treatment Discontinuation and Cost Effectiveness of Third-Line Therapies in Advanced Colorectal Cancer: Real-World Evidence from the NIH All of Us Research Program. Drugs - Real World Outcomes. 2026;13(1):121-131. doi:10.1007/s40801-026-00539-9

BibTeX
@article{Kiel2026,
  author = {Kiel, Patrick J and McGiffin, Mark W and Skaar, Todd C and Preston, Michael A},
  title = {Time to Treatment Discontinuation and Cost Effectiveness of Third-Line Therapies in Advanced Colorectal Cancer: Real-World Evidence from the NIH All of Us Research Program},
  journal = {Drugs - Real World Outcomes},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {121--131},
  doi = {10.1007/s40801-026-00539-9}
}
Kostenlos starten →